
CAS: 1675201-90-7
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | 1-[[3-bromo-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylicacid REF: IN-DA01EPQ9CAS: 1675201-90-7 | 98% | A consultar | Jue 27 Mar 25 |
![]() | BMS-8 REF: TM-T26859CAS: 1675201-90-7 | 99.06% | 39,00 €~1.359,00 € | Jue 03 Abr 25 |
![]() | BMS-8 REF: 3D-ASC20190CAS: 1675201-90-7 | Min. 95% | A consultar | Jue 08 May 25 |

1-[[3-bromo-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylicacid
CAS:1675201-90-7
Fórmula:
C27H28BrNO3
Pureza:
98%
Forma y color:
Solid
Peso molecular:
494.4201
Ref: IN-DA01EPQ9
1g | 638,00 € | ||
1mg | 116,00 € | ||
50mg | 125,00 € | ||
100mg | 150,00 € | ||
250mg | 252,00 € |
Entrega estimada en Estados Unidos, el Jueves 27 de Marzo de 2025

BMS-8
CAS:1675201-90-7
BMS-8 is a novel inhibitor of the PD-1/PD-L1 interaction (IC50: 7.2 μM) by binding directly …
Fórmula:
C27H28BrNO3
Pureza:
99.06%
Forma y color:
Solid
Peso molecular:
494.42
Ref: TM-T26859
1mg | 39,00 € | ||
5mg | 84,00 € | ||
10mg | 131,00 € | ||
25mg | 269,00 € | ||
50mg | 432,00 € | ||
100mg | 638,00 € | ||
500mg | 1.359,00 € | ||
1mL*10mM (DMSO) | 95,00 € |
Entrega estimada en Estados Unidos, el Jueves 3 de Abril de 2025

BMS-8
CAS:1675201-90-7
Please enquire for more information about BMS-8 including the price, delivery time and more detailed …
Fórmula:
C27H28BrNO3
Pureza:
Min. 95%
Peso molecular:
494.4 g/mol
Ref: 3D-ASC20190
10mg | 998,00 € | ||
25mg | 1.360,00 € | ||
50mg | 2.176,00 € | ||
100mg | 3.401,00 € |
Entrega estimada en Estados Unidos, el Jueves 8 de Mayo de 2025